comparemela.com

Latest Breaking News On - Ozone pharmaceuticals - Page 1 : comparemela.com

Ozone Pharma eyes Rs 1000 crore topline in next 3 years

Ozone Pharma eyes Rs 1000 crore topline in next 3 years
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Ozone Pharmaceuticals eyes Rs 1,000 crore topline in next 3 years

Latest News | Ozone Pharma Eyes Rs 1k Cr Topline in Next 3 Years

Get latest articles and stories on Latest News at LatestLY. Ozone Pharmaceuticals on Wednesday said it is eying a Rs 1,000 crore turnover in the next three years and has launched the 'Molecule initiative' with an aim to become the world's foremost pain management company. Latest News | Ozone Pharma Eyes Rs 1k Cr Topline in Next 3 Years.

Ozone Pharmaceuticals recently launched a new division AdLife; Currently in the inception stages

New Delhi [India], November 25 (ANI/PNN): On August 4, 2022, Ozone Pharmaceutical's AdLife extends their vision of "adding years to life and life to years", AdLife "ADDS LIFE TO LIFE". AdLife further gets wings through the trust of doctors and patients Ozone Group has gathered in its 3 decades of practice. Offering treatments that support holistically from conception to gestation. Ozone Pharmaceuticals, founded in 1991 is a formulation driven manufacturer and marketer of prescription medications in therapy areas like cardio, diabetes, chronic pain management, critical care and gynaecology. With AdLife, entering yet another therapy area, and a sought after one at that - fertility, Ozone Pharmaceuticals has expanded its presence in the women's health segment. We asked Mr. SC Sehgal, Chairman and Managing Director, Ozone Group his inspiration behind expanding into fertility assistance. He said "AdLife is important to me, for me it is not a business, its st

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.